Table 3.

Summary of the studied population’s clinical and epidemiological data.

	Overall (n = 57)	C. burnetii Seroreactive (n = 26)	C. burnetii Non-Reactive (n = 31)
Age-Median (IR)	33 (22–49)	33 (21–53)	33 (23–48)
Gender, n (%)
Male	32 (66%)	17 (65%)	15 (48%)
Female	25 (42%)	9 (35%)	16 (52%)
Symptomatology, n (%)
Fever	24 (42%)	10 (38%)	14 (45%)
Nausea	7 (12%)	4 (15%)	3 (10%)
Endocarditis	6 (11%)	4 (15%)	2 (6%)
Hemorrhagic manifestations	1 (2%)	0	1 (3%)
Myalgia	13 (23%)	4 (15%)	9 (29%)
Respiratory manifestations	11 (19%)	3 (12%)	8 (26%)
Prostration	18 (32%)	6 (23%)	12 (39%)